Manav Korpal has not added Biography.
If you are Manav Korpal and would like to personalize this page please email our Author Liaison for assistance.
Interactions between the megakaryocyte/platelet-specific beta1 tubulin and the secretory leukocyte protease inhibitor SLPI suggest a role for regulated proteolysis in platelet functions.
Blood Dec, 2004 | Pubmed ID: 15315966
Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis.
Blood May, 2006 | Pubmed ID: 16434494
RanBP10 is a cytoplasmic guanine nucleotide exchange factor that modulates noncentrosomal microtubules.
The Journal of biological chemistry May, 2008 | Pubmed ID: 18347012
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.
The Journal of biological chemistry May, 2008 | Pubmed ID: 18411277
The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis.
RNA biology Jul-Sep, 2008 | Pubmed ID: 19182522
Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis.
Nature medicine Aug, 2009 | Pubmed ID: 19597504
Targeting the transforming growth factor-beta signalling pathway in metastatic cancer.
European journal of cancer (Oxford, England : 1990) May, 2010 | Pubmed ID: 20307969
MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells.
Journal of translational medicine , 2011 | Pubmed ID: 21426561
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
Nature medicine Sep, 2011 | Pubmed ID: 21822286
Isocitrate dehydrogenase (IDH) mutations promote a reversible ZEB1/microRNA (miR)-200-dependent epithelial-mesenchymal transition (EMT).
The Journal of biological chemistry Dec, 2012 | Pubmed ID: 23038259
An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide).
Cancer discovery Sep, 2013 | Pubmed ID: 23842682
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。